232 related articles for article (PubMed ID: 29863497)
21. Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma.
Arseneault M; Monlong J; Vasudev NS; Laskar RS; Safisamghabadi M; Harnden P; Egevad L; Nourbehesht N; Panichnantakul P; Holcatova I; Brisuda A; Janout V; Kollarova H; Foretova L; Navratilova M; Mates D; Jinga V; Zaridze D; Mukeria A; Jandaghi P; Brennan P; Brazma A; Tost J; Scelo G; Banks RE; Lathrop M; Bourque G; Riazalhosseini Y
Sci Rep; 2017 Mar; 7():44876. PubMed ID: 28332632
[TBL] [Abstract][Full Text] [Related]
22. Histone demethylase KDM7A controls androgen receptor activity and tumor growth in prostate cancer.
Lee KH; Hong S; Kang M; Jeong CW; Ku JH; Kim HH; Kwak C
Int J Cancer; 2018 Dec; 143(11):2849-2861. PubMed ID: 30183076
[TBL] [Abstract][Full Text] [Related]
23. Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor.
Willmann D; Lim S; Wetzel S; Metzger E; Jandausch A; Wilk W; Jung M; Forne I; Imhof A; Janzer A; Kirfel J; Waldmann H; Schüle R; Buettner R
Int J Cancer; 2012 Dec; 131(11):2704-9. PubMed ID: 22447389
[TBL] [Abstract][Full Text] [Related]
24. KDM5D-mediated H3K4 demethylation is required for sexually dimorphic gene expression in mouse embryonic fibroblasts.
Mizukami H; Kim JD; Tabara S; Lu W; Kwon C; Nakashima M; Fukamizu A
J Biochem; 2019 Apr; 165(4):335-342. PubMed ID: 30541083
[TBL] [Abstract][Full Text] [Related]
25. Proteomics based identification of KDM5 histone demethylases associated with cardiovascular disease.
Mokou M; Klein J; Makridakis M; Bitsika V; Bascands JL; Saulnier-Blache JS; Mullen W; Sacherer M; Zoidakis J; Pieske B; Mischak H; Roubelakis MG; Schanstra JP; Vlahou A
EBioMedicine; 2019 Mar; 41():91-104. PubMed ID: 30826357
[TBL] [Abstract][Full Text] [Related]
26. ETV4 promotes the progression of gastric cancer through regulating KDM5D.
Cai LS; Chen QX; Fang SY; Lian MQ; Lian MJ; Cai MZ
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2442-2451. PubMed ID: 32196595
[TBL] [Abstract][Full Text] [Related]
27. LSD1-Mediated Epigenetic Reprogramming Drives CENPE Expression and Prostate Cancer Progression.
Liang Y; Ahmed M; Guo H; Soares F; Hua JT; Gao S; Lu C; Poon C; Han W; Langstein J; Ekram MB; Li B; Davicioni E; Takhar M; Erho N; Karnes RJ; Chadwick D; van der Kwast T; Boutros PC; Arrowsmith CH; Feng FY; Joshua AM; Zoubeidi A; Cai C; He HH
Cancer Res; 2017 Oct; 77(20):5479-5490. PubMed ID: 28916652
[TBL] [Abstract][Full Text] [Related]
28. c-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer.
Maina PK; Shao P; Liu Q; Fazli L; Tyler S; Nasir M; Dong X; Qi HH
Oncotarget; 2016 Nov; 7(46):75585-75602. PubMed ID: 27689328
[TBL] [Abstract][Full Text] [Related]
29. Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells.
Fan L; Zhang F; Xu S; Cui X; Hussain A; Fazli L; Gleave M; Dong X; Qi J
Proc Natl Acad Sci U S A; 2018 May; 115(20):E4584-E4593. PubMed ID: 29712835
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic and osteolytic functions of histone demethylase NO66 in castration-resistant prostate cancer.
Sinha KM; Bagheri-Yarmand R; Lahiri S; Lu Y; Zhang M; Amra S; Rizvi Y; Wan X; Navone N; Ozpolat B; Logothetis C; Gagel RF; Huard J
Oncogene; 2019 Jun; 38(25):5038-5049. PubMed ID: 30858546
[TBL] [Abstract][Full Text] [Related]
31. Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling.
Karanika S; Karantanos T; Li L; Wang J; Park S; Yang G; Zuo X; Song JH; Maity SN; Manyam GC; Broom B; Aparicio AM; Gallick GE; Troncoso P; Corn PG; Navone N; Zhang W; Li S; Thompson TC
Cell Rep; 2017 Feb; 18(8):1970-1981. PubMed ID: 28228262
[TBL] [Abstract][Full Text] [Related]
32. Reversible lysine-specific demethylase 1 antagonist HCI-2509 inhibits growth and decreases c-MYC in castration- and docetaxel-resistant prostate cancer cells.
Gupta S; Weston A; Bearrs J; Thode T; Neiss A; Soldi R; Sharma S
Prostate Cancer Prostatic Dis; 2016 Dec; 19(4):349-357. PubMed ID: 27349498
[TBL] [Abstract][Full Text] [Related]
33. Increased Expression of Y-Encoded Demethylases During Differentiation of Human Male Neural Stem Cells.
Pottmeier P; Doszyn O; Peuckert C; Jazin E
Stem Cells Dev; 2020 Dec; 29(23):1497-1509. PubMed ID: 33040644
[TBL] [Abstract][Full Text] [Related]
34. Inhibiting Wee1 and ATR kinases produces tumor-selective synthetic lethality and suppresses metastasis.
Bukhari AB; Lewis CW; Pearce JJ; Luong D; Chan GK; Gamper AM
J Clin Invest; 2019 Mar; 129(3):1329-1344. PubMed ID: 30645202
[TBL] [Abstract][Full Text] [Related]
35. LSD1 activates a lethal prostate cancer gene network independently of its demethylase function.
Sehrawat A; Gao L; Wang Y; Bankhead A; McWeeney SK; King CJ; Schwartzman J; Urrutia J; Bisson WH; Coleman DJ; Joshi SK; Kim DH; Sampson DA; Weinmann S; Kallakury BVS; Berry DL; Haque R; Van Den Eeden SK; Sharma S; Bearss J; Beer TM; Thomas GV; Heiser LM; Alumkal JJ
Proc Natl Acad Sci U S A; 2018 May; 115(18):E4179-E4188. PubMed ID: 29581250
[TBL] [Abstract][Full Text] [Related]
36. Multilocus loss of DNA methylation in individuals with mutations in the histone H3 lysine 4 demethylase KDM5C.
Grafodatskaya D; Chung BH; Butcher DT; Turinsky AL; Goodman SJ; Choufani S; Chen YA; Lou Y; Zhao C; Rajendram R; Abidi FE; Skinner C; Stavropoulos J; Bondy CA; Hamilton J; Wodak S; Scherer SW; Schwartz CE; Weksberg R
BMC Med Genomics; 2013 Jan; 6():1. PubMed ID: 23356856
[TBL] [Abstract][Full Text] [Related]
37. The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells.
Wilson S; Fan L; Sahgal N; Qi J; Filipp FV
Oncotarget; 2017 May; 8(18):30328-30343. PubMed ID: 28416760
[TBL] [Abstract][Full Text] [Related]
38. Lysine demethylases KDM6A and UTY: The X and Y of histone demethylation.
Gažová I; Lengeling A; Summers KM
Mol Genet Metab; 2019 May; 127(1):31-44. PubMed ID: 31097364
[TBL] [Abstract][Full Text] [Related]
39. Galiellalactone induces cell cycle arrest and apoptosis through the ATM/ATR pathway in prostate cancer cells.
García V; Lara-Chica M; Cantarero I; Sterner O; Calzado MA; Muñoz E
Oncotarget; 2016 Jan; 7(4):4490-506. PubMed ID: 26683224
[TBL] [Abstract][Full Text] [Related]
40. Human Sex Matters: Y-Linked Lysine Demethylase 5D Drives Accelerated Male Craniofacial Osteogenic Differentiation.
Merten M; Greiner JFW; Niemann T; Grosse Venhaus M; Kronenberg D; Stange R; Wähnert D; Kaltschmidt C; Vordemvenne T; Kaltschmidt B
Cells; 2022 Feb; 11(5):. PubMed ID: 35269444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]